In this interesting graph, Synthesis Capital, a VC, summarized the numerous studies and reports on alternative proteins’ market potential, notably cellular agriculture and precision fermentation.
What we learn (beyond the S-curve, which is the fund’s thesis) is that these projections are widely divergent… and should be taken with a grain of salt.
